Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H16N5S |
| Molecular Weight | 334.418 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 1 |
SHOW SMILES / InChI
SMILES
CC1=C(C)N=C(S1)[N+]2=NC(=NN2C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=FTZIQBGFCYJWKA-UHFFFAOYSA-N
InChI=1S/C18H16N5S/c1-13-14(2)24-18(19-13)23-21-17(15-9-5-3-6-10-15)20-22(23)16-11-7-4-8-12-16/h3-12H,1-2H3/q+1
| Molecular Formula | C18H16N5S |
| Molecular Weight | 334.418 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16216776
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776
Thiazolyl Blue is a membrane-permeable yellow dye that is reduced by mitochondrial reductases in living cells to form the dark blue product. The net positive charge on Thiazolyl Blue appears to be the predominant factor involved in their cellular uptake via the plasma membrane potential. Thiazolyl Blue is used as a direct indicator of cytotoxicity (such as for screening cancer drugs), proliferation and apoptosis. Thiazolyl Blue is also an electron acceptor used for studying NADP-dependent dehydrogenases. Thiazolyl Blue reduction is associated not only with mitochondria, but also with the cytoplasm and with nonmitochondrial membranes including the endosome/lysosome compartment and the plasma membrane. Biological Applications: cell viability assay; microbial growth assays; DNA quantification assays; tissue viability assays; detecting enzymes; measuring membrane potential; treating Alzheimer’s disease, asthma, cancer. Because Thiazolyl Blue forms an insoluble formazan it has usually been applied in endpoint assays.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Succinate dehydrogenase Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776 |
|||
Target ID: Oxidoreductases Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Exocytosis of MTT formazan could exacerbate cell injury. | 2012-06 |
|
| Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. | 2004-10 |
|
| Inactivation of aconitase during the apoptosis of mouse cerebellar granule neurons induced by a deprivation of membrane depolarization. | 2003-02-15 |
|
| The use of thiazolyl blue for the detection of dehydrogenases on starch gels. | 1966-10 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:30:46 GMT 2025
by
admin
on
Mon Mar 31 23:30:46 GMT 2025
|
| Record UNII |
010O4LC9TS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13146-93-5
Created by
admin on Mon Mar 31 23:30:46 GMT 2025 , Edited by admin on Mon Mar 31 23:30:46 GMT 2025
|
PRIMARY | |||
|
53233
Created by
admin on Mon Mar 31 23:30:46 GMT 2025 , Edited by admin on Mon Mar 31 23:30:46 GMT 2025
|
PRIMARY | |||
|
DTXSID701202933
Created by
admin on Mon Mar 31 23:30:46 GMT 2025 , Edited by admin on Mon Mar 31 23:30:46 GMT 2025
|
PRIMARY | |||
|
64966
Created by
admin on Mon Mar 31 23:30:46 GMT 2025 , Edited by admin on Mon Mar 31 23:30:46 GMT 2025
|
PRIMARY | |||
|
010O4LC9TS
Created by
admin on Mon Mar 31 23:30:46 GMT 2025 , Edited by admin on Mon Mar 31 23:30:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |